Cargando…
Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
To the best of our knowledge, non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants, have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), affected by malignant disease. However, their use in patients with cancer is increasing, w...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Kare Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141434/ https://www.ncbi.nlm.nih.gov/pubmed/31911561 http://dx.doi.org/10.14744/AnatolJCardiol.2019.30766 |